Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Aarhus
Leiden University Medical Center
Shanghai Pulmonary Hospital, Shanghai, China
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Fundación GECP
Medipol University
RenJi Hospital
The First Affiliated Hospital of Guangzhou Medical University
University of Alabama at Birmingham
Instituto Nacional de Cancerologia de Mexico
All India Institute of Medical Sciences, Bhubaneswar
Fundación GECP
Fundación GECP
Fundación GECP
Fundación GECP
Stanford University
Stanford University
University of Washington
Assiut University
Aga Khan University
Milton S. Hershey Medical Center
Nanfang Hospital, Southern Medical University
The University of Queensland
University Hospital Augsburg
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Alberta
Erasme University Hospital
Centre Hospitalier Universitaire de Tivoli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Ain Shams University
The Methodist Hospital Research Institute
Centro Universitário de Anapolis
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Cologne
Hallym University Kangnam Sacred Heart Hospital
University Health Network, Toronto
Sichuan Cancer Hospital and Research Institute
Shanghai Pulmonary Hospital, Shanghai, China
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Sichuan Cancer Hospital and Research Institute
University of New Mexico
New Mexico Cancer Research Alliance
M.D. Anderson Cancer Center
University of Aarhus